Identification of a New Peptide for Fibrosarcoma Tumor Targeting and Imaging In Vivo

Figure 4

Biodistribution of TK4 in tumor-bearing mouse. Animals receiving IV injected ¹³¹I-FITC-TK4 were sacrificed at 1, 4, or 24 hr postinjection. Tumors and other organs were removed and measured for the radioactivity. Results were calculated as percentage of injected dose per gram of tissue (% ID/g). Error bars indicate SEM. 𝑁=5 at each time point